Benefit of Implantable Cardioverter Defibrillator Therapy in Patients with Advanced Renal Impairment: A Competing Risk Analysis from the Madit Trials
Department
Medicine
Document Type
Conference Proceeding
Publication Title
Circulation
Conference Name
American Heart Association's 2021 Scientific Sessions
Conference Date
2021-01-01
First Page
A11967
Volume
144
Issue
Suppl_1
Publication Date
11-8-2021
Recommended Citation
Goldenberg, I., Aktas, M., & Rao, M. (2021). Benefit of Implantable Cardioverter Defibrillator Therapy in Patients with Advanced Renal Impairment: A Competing Risk Analysis from the Madit Trials. Circulation, 144 (Suppl_1), A11967. Retrieved from https://scholar.rochesterregional.org/rrhpubs/1265
COinS
Comments
See full list of authors at journal website.
ELECTROPHYSIOLOGY AND ARRHYTHMIAS
SESSION TITLE: SUDDEN CARDIAC DEATH AND CARDIAC IMPLANTABLE ELECTRONIC DEVICES: WHAT’S NEW IN RISK PREDICTION?
Abstract: 11967